References
- Allison DB, Saunders SE: Obesity in North America. An overview. Med Clin North Am 2000; 84:305–332
- Flegal KM, Carroll MD, Kuczmarski RJ, Johnson CL: Overweight and obesity in the United States: prevalence and trends, 1960–1994. Int J Obes Relat Metab Disord 1998; 22:39–47
- Aronne LJ, Segal KR: Weight gain in the treatment of mood disorders. J Clin Psychiatry 2003; 64(8, Suppl):22–29
- Kawachi I: Physical and psychological consequences of weight gain. J Clin Psychiatry 1999;60(21, Suppl):5–9
- Coodin S: Body mass index in persons with schizophrenia. Can J Psychiatry 2001; 46:549–555
- Allison DB, Fontaine KR, Heo M, Mentore JL, Cappelleri JC, Chandler LP, Weiden PJ, Cheskin LJ: The distribution of body mass index among individuals with and without schizophrenia. J Clin Psychiatry 1999; 60:215–220
- Weiser M, Knobler H, Lubin G, Nahon D, Kravitz E, Caspi A, Noy S, Knobler HY, Davidson M: Body mass index and future schizophrenia in Israeli male adolescents. J Clin Psychiatry 2004; 65:1546–1549
- Onyike CU, Crum RM, Lee HB, Lyketsos CG, Eaton WW: Is obesity associated with major depression? Results from the Third National Health and Nutrition Examination Survey. Am J of Epidemiol 2003; 158:1139–1147
- Sansone RA, Wiederman MW, Sansone LA, Monteith D: Obesity and borderline personality symptomatology: comparison of a psychiatric versus primary care sample. Int J Obes Relat Metab Disord 2001; 25:299–300
- Nasrallah H: A review of the effect of atypical antipsychotics on weight. Psychoneuroendocrinology 2003; 28(1, Suppl):83–96
- Chengappa KN, Chalasani L, Brar JS, Parepally H, Houck P, Levine J: Changes in body weight and body mass index among psychiatric patients receiving lithium, valproate, or topiramate: an open-label, nonrandomized chart review. Clin Ther 2002; 24:1576–1584
- Fava M, Judge R, Hoog SL, Nilsson ME, Koke SC: Fluoxetine versus sertraline and paroxetine in major depressive disorder: Changes in weight with long-term treatment. J Clin Psychiatry 2000; 61:863–867
- Putnam D, Williams RA, Weese D, Whitlock K: The effect of inpatient psychiatric hospitalization on weight gain in children and adolescents. Psychiatr Hosp 1990; 21:119–123
- Martin A, Landau J, Leebens P, Ulizio K, Cicchetti D, Scahill L, Leckman JF: Risperidone-associated weight gain in children and adolescents: A retrospective chart review. J Child Adolesc Psychopharmacol 2000; 10:259–268
- Gothelf D, Falk B, Singer P, Kairi M, Phillip M, Zigel L, Poraz I, Frishman S, Constantini N, Zalsman G, Weizman A, Apter A: Weight gain associated with increased food intake and low habitual activity levels in male adolescent schizophrenic inpatients treated with olanzapine. J Am Acad Child Adolesc Psychiatry 2002; 41:337–343
- Thompson EE, Neighbors HW, Munday C, Trierweiler S: Length of stay, referral to aftercare, and rehospitalization among psychiatric inpatients. Psychiatr Serv 2003; 54:1271–1276
- Leischow SJ, Stitzer ML: Effects of smoking cessation on caloric intake and weight gain in an inpatient unit. Psychopharmacology 1991; 104:522–526
- Paton C, Esop R, Young C, Taylor D: Obesity, dyslipidaemias and smoking in an inpatient population treated with antipsychotic drugs. Acta Psychiatr Scand 2004; 110:299–305
- Swinburn BA, Caterson I, Seidell JC, James WP: Diet, nutrition and the prevention of excess weight gain and obesity. Public Health Nutr 2004; 7:123–146